Plasma Rich in Growth Factors: Preliminary Results of Use in the Preparation of Future Sites for Implants

International Journal of Oral and Maxillofacial Implants

Volumn 14, Issue 4, 1999, Pages 529-535

  Anitua, Eduardo ^a,b  

^a Implantology and Oral Rehabilitation   (Spain)

^b NONE   (Spain)

Author keywords

Growth factors; Plasma growth factors

Indexed keywords

GROWTH PROMOTOR; LYMPHOTOXIN; PLATELET DERIVED GROWTH FACTOR;

ADULT; ARTICLE; BLOOD; BONE REGENERATION; BONE TRANSPLANTATION; CASE REPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; JAW; MALE; MIDDLE AGED; PATHOLOGY; PERIODONTAL DISEASE; PLASMAPHERESIS; RANDOMIZED CONTROLLED TRIAL; TOOTH EXTRACTION; TOOTH FRACTURE; TOOTH IMPLANTATION; TOOTH SOCKET; WOUND HEALING;

ADULT; ALVEOLAR PROCESS; BONE REGENERATION; BONE TRANSPLANTATION; DENTAL IMPLANTATION, ENDOSSEOUS; FEMALE; GROWTH SUBSTANCES; HUMANS; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; PERIODONTAL DISEASES; PLASMAPHERESIS; PLATELET-DERIVED GROWTH FACTOR; TOOTH EXTRACTION; TOOTH FRACTURES; TOOTH SOCKET; WOUND HEALING;

EID: 0033163437     PISSN: 08822786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Nevins M. Bone formation in the goat maxillary sinus induced by absorbable collagen sponge implants impregnated with recombinant human bone morphogenetic pro-tein-2. Int J Periodontics Restorative Dent 1996;16:9-19.
2. Boyne P, Marx R, Nevins M, Triplett G, Lazaro E, Lilly L, et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent 1997;17:11-25.
3. Howell T, Fiorellini J, Jones A, Alder M, Nummikoski P, Lazaro M, et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int J Periodontics Restorative Dent 1997;17:125-139.
4. Melanotte PL, Pavanini G, Turra S. Le cisti ossee solitarie. Clin Orthop 1975;26:70-86.
5. Neer CS, Francis KC, Marcove RC, Terz J, Carbonara PN. Treatment of UBC: A follow-up study of one hundred and seventy-five cases. J Bone Joint Surg [Am] 1966;48: 731-745.
6. Rosenberg M, Mortenson W. Considerations in the corticosteroid treatment of bone cysts. J Pediatr Orthop 1989; 9:240-243.
7. Schlag G, Redl H. The influence of fibrin sealant on demineralized bone matrix-dependent osteoinduction. A quantitative and qualitative study in rats. Clin Orthop 1989;238:282-287.
8. Tayapongsak P, O'Brien DA, Monteiro CB, Arceo-Dias LL. Autologous fibrin adhesive in mandibular reconstruction with particulate cancellous bone and marrow. J Oral Maxillofac Surg 1994;52(2):161-166.
9. Antonaides HN, Williams LT. Human platelet-derived growth factor: Structure and functions. Federation Proc 1983;42:2630-2634.
10. Bowen-Pope DF, Vogel A, Ross R. Production of platelet-derived growth factor-like molecules and reduced expression of platelet-derived growth factor receptors accompany transformation by a wide spectrum of agents. Proc Natl Acad Sci USA 1984;81:2396-2400.
11. Marx RE, Saunders TR. Reconstruction and Rehabilitation of Cancer Patients. Reconstructive Prosthetic Oral and Maxillofacial Surgery. Philadelphia: Saunders, 1986: 347-427.
12. Miyazono K, Ten-Dijke P, Ichiyo H, Heldin CH. Receptors for transforming growth factor-beta. Adv Immunol 1994; 15:181-220.
13. Roberts AB, Spron MB. Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors 1993;8:1-9.
14. Arbes H, Bösch P, Salzer M. First clinical experience with heterologous cancellous bone grafting, combined with the fibrin adhesive system (F.A.S.). Arch Orthop Trauma Surg 1981;98:183-188.
15. Bösch P, Braun F, Eschberger S, Kovac W, Spängler HP. Die Beeinflussung der Knochenheilung durch hochkonzentriertes Fibrin. Arch Orthop Unfallchir 1997;89:259-273.
16. Bösch P, Lintner F, Arbes H, Brand G. Experimental investigations of the effect of the fibrin adhesive on the Kiel heterologous bone graft. Arch Orthop Trauma Surg 1980;96: 177-185.
17. Braun A, Brüwer W, Schumacher G, Heine WD. Die fibrinolytische Aktivität im traumatisierten Kniegelenk und ihre Bedeutung bei der Fibrinklebung osteochondraler Fragments. Hefte Unfallheilkd 1980;148:814-815.
18. Meyers MH, Herron M. A fibrin adhesive seal for the repair of osteochondral fracture fragments. Clin Orthop 1984;182:258-263.
19. Zilch H, Talke M. Klebung kleiner osteochondraler Fragmente in der Handchirurgie mit dem Fibrinkleber. Klinische Erfahrungen. Handchirurgie 1980;12:77-81.
20. Antoniades HN. Human platelet-derived growth factor (PDGF): Purification of PDGF-I and PDGF-II and separation of their reduced subunits. Proc Nat Acad Sci USA 1981;78(12):7314-7317.
21. Rappolee DA, Mark D, Banda MJ, Werb Z. Wound macrophages express TGFa and other growth factors in vivo: Analysis by Mrna phenotyping. Science 1988;247: 708-712.
22. Sitaras NM, Sariban E, Pantazis P, Zetter B, Antoniades HN. Human iliac affery endothelial cells express both genes encoding the chains of platelet-derived growth factor (PDGF) and synthesize PDGF-like mitogen. J Cell Physiol 1987;132:376-380.
23. Antoniades HN, Calanopoulos T, Neville-Golden J, Kirtsy CH, Lynch SE. Injury induces in vivo expression of platelet-derived growth factor (PDGF) and PDGF receptor mRNAs in skin epithelial cells and PDGF mRNA in connective tissue fibroblasts. Proc Natl Acad Sci USA 1991;88: 565-569.
24. Hauschka PW, Mavrakos AE, Iafrati MD, Doleman SE, Klagsbrun M. Growth factors in bone matrix. J Biol Chem 1986;261(27):12665-12674.
25. Deuel TF, Huang JS, Proffitt RT, Baenziger JU, Chang D, Kennedy BB. Human platelet-derived growth factor. J Biol Chem 1981;256(17):8896-8899.
26. Lynch SE, Niwon JC, Colvin RB, Antoniades HN. Role of platelet-derived growth factor in wound healing: Synergistic effects with other growth factors. Proc Natl Acad Sci USA 1987;84:7696-7700.
27. Serrano Cuenca V. Growth factors: A new therapeutical approach? Periodoncia 1997;7(N°2) Fasc. 1:99-115.
28. Raines EW, Ross R. Platelet-derived growth factor. J Biol Chem 1982;237(9):5154-5160.
29. Antoniades HN, Hunkapiller MW. Human platelet-derived growth factor (PDGF): Amino-terminal amino acid sequence. Science 1983;220:963-965.
30. Betsholtz CH, Johnsson A, Heldin CH, Westermark B, Lind P, Urdea MS, et al. CDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumourcellines. Nature 1986; 320:659-670.
31. Burgess AW. Epidermal growth factor and transforming growth factor A. Br Med Bull 1989;45(2):401-424.
32. Derynck R, Jarret JA, Chen EY, Goeddel DV. The murine transforming growth factor-ß precursor. J Biol Chem 1986; 261(10):4337-4379.
33. Keski-Oja J, Leof EB, Lyons RM, Coffey RJ, Moses HL. Transforming growth factors and control of neoplastic cell growth. J Cell Biochem 1987;33:95-107.
34. Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB. Transforming growth factor-in human platelets. J Biol Chem 1983;258(11):7155-7160.
35. Centrella M, Massagué J, Canalis E. Human platelet-derived transforming growth factor-ß stimulates parameters of bone growth in fetal rat calvariae. Endocrinology 1986;119:2306-2312.
36. Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, et al. Human transforming growth factor-ß complementary DNA sequence and expression in normal and transformed cells. Nature 1985;316:701-705.
37. Derynck R, Lindquist PB, Lee A, Wen D, Tamm J, Craycar JL, et al. A new type of transforming growth factor-ß, TGF-ß3. EMBO J 1987;7(12):3737-3743.
38. Duke PT, Hansen P, Iwata KK, Pieler C, Foulkes JG. Identification of another member of the transforming growth factor type ß gene family. Proc Natl Acad Sci USA 1988; 85:4715-4719.
39. Soslau G, Morgan DA, Jaffe JS, Brodsky I, Wang Y. Cytokine mRNA expression in human platelets and a megakaryocytic cell line and cytokine modulation of platelet function. Cytokine 1997;9(6):405-411.
40. Giannobile WV, Finkelman RD, Lynch S. Comparison of canine and nonhuman primate animal models for periodontal regenerative therapy: Results following a single administration of PDGF/IGF-I. J Periodontol 1994;65: 1158-1168.
41. Wang H-L, Pappert TD, Castelli WA, Chiego DJ, Shyr Y, Smith BA. The effect of platelet-derived growth factor on the cellular response of the periodontium: An autoradiographic study on dogs. J Periodontol 1994;65:429-436.
42. Howell HT, Fiorellini JP, Paquette DW, Offenbacher S, Giannobile WV, Lynch SE. A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J Periodontol 1997;68:1186-1193.